340 related articles for article (PubMed ID: 8262640)
1. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.
Schlesinger LS; Horwitz MA
Infect Immun; 1994 Jan; 62(1):280-9. PubMed ID: 8262640
[TBL] [Abstract][Full Text] [Related]
2. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes.
Schlesinger LS; Horwitz MA
J Exp Med; 1991 Nov; 174(5):1031-8. PubMed ID: 1940785
[TBL] [Abstract][Full Text] [Related]
3. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.
Schlesinger LS; Horwitz MA
J Clin Invest; 1990 Apr; 85(4):1304-14. PubMed ID: 2138634
[TBL] [Abstract][Full Text] [Related]
4. Activation of the human complement system by phenolic glycolipid 1 of Mycobacterium leprae.
Ramanathan VD; Parkash O; Tyagi P; Sengupta U; Ramu G
Microb Pathog; 1990 Jun; 8(6):403-10. PubMed ID: 2266854
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
[TBL] [Abstract][Full Text] [Related]
7. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
[TBL] [Abstract][Full Text] [Related]
8. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
Britton WJ; Garsia RJ; Basten A
Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
11. A potential role for complement in immune evasion by Mycobacterium leprae.
Callegaro-Filho D; Shrestha N; Burdick AE; Haslett PA
J Drugs Dermatol; 2010 Nov; 9(11):1373-82. PubMed ID: 21061760
[TBL] [Abstract][Full Text] [Related]
12. Armadillo IgG and IgM antibody responses to phenolic glycolipid-I during experimental infection with M. leprae.
Vadiee AR; Shannon EJ; Gillis TP; Mshana RN; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):422-7. PubMed ID: 3047283
[TBL] [Abstract][Full Text] [Related]
13. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
[TBL] [Abstract][Full Text] [Related]
14. Detection of Anti-Phenolic Glycolipid-I antibody in sera from tuberculosis patients in Bandung, West Java, Indonesia.
Gunawan H; Roslina N; Agusni JH; Kulsum ID; Makarti K; Hindritiani R; Suwarsa O
Int J Mycobacteriol; 2019; 8(2):166-169. PubMed ID: 31210160
[TBL] [Abstract][Full Text] [Related]
15. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
Spencer JS; Brennan PJ
Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
[TBL] [Abstract][Full Text] [Related]
16. Detection of IgA anti-PGL-I specific antigen to Mycobacterium leprae in mangabey monkeys inoculated with M. leprae.
Saad MH; Gormus BJ; Cho SN; Bernheimer H; Schwerer B
Lepr Rev; 1995 Dec; 66(4):296-306. PubMed ID: 8637383
[TBL] [Abstract][Full Text] [Related]
17. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
18. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
Desforges S; Bobin P; Brethes B; Huerre M; Moreau JP; Bach MA
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
[TBL] [Abstract][Full Text] [Related]
19. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
20. CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy.
Doz-Deblauwe É; Carreras F; Arbues A; Remot A; Epardaud M; Malaga W; Mayau V; Prandi J; Astarie-Dequeker C; Guilhot C; Demangel C; Winter N
Front Immunol; 2019; 10():2913. PubMed ID: 31921172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
